Investigation of Hepatitis B and Hepatitis C in Taiwan

Hepatitis C Clinical Trial

Official title:

Investigation of Hepatitis B and Hepatitis C in Taiwan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00946010
• Other study ID #: 200801059R
• Status: Completed
• Phase: N/A
• First received: April 1, 2008
• Last updated: January 20, 2011
• Start date: April 2008
• Est. completion date: January 2011

Study information

• Verified date: January 2011
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Description:

The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6228
• Est. completion date: January 2011
• Est. primary completion date: August 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 23 Years and older

Eligibility

Inclusion Criteria:

• Born before 1985/01/01

• HBV or HCV carriers

Exclusion Criteria:

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C

Intervention

Biological:
• blood sampling and abdominal sonography
10cc blood sampling and abdominal sonography

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	genotype and DNA level or RNA level of HBV and HCV virus		once during Mar. 2008- Jan. 2011	No